Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
17.23%
operating margin TTM
31.0%
revenue TTM
9.74 Billion
revenue per share TTM
66.55$
valuation ratios | |
|---|---|
| pe ratio | 12.85 |
| peg ratio | 12.97 |
| price to book ratio | 1.20 |
| price to sales ratio | 2.22 |
| enterprise value multiple | 8.09 |
| price fair value | 1.20 |
profitability ratios | |
|---|---|
| gross profit margin | 78.54% |
| operating profit margin | 31.0% |
| pretax profit margin | 20.12% |
| net profit margin | 17.23% |
| return on assets | 5.82% |
| return on equity | 10.06% |
| return on capital employed | 13.04% |
liquidity ratio | |
|---|---|
| current ratio | 1.35 |
| quick ratio | 0.90 |
| cash ratio | 0.43 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 441.69 |
| operating cycle | 495.81 |
| days of payables outstanding | 76.15 |
| cash conversion cycle | 419.66 |
| receivables turnover | 6.74 |
| payables turnover | 4.79 |
| inventory turnover | 0.83 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.17 |
| debt equity ratio | 0.28 |
| long term debt to capitalization | 0.22 |
| total debt to capitalization | 0.22 |
| interest coverage | 15.43 |
| cash flow to debt ratio | 0.59 |
cash flow ratios | |
|---|---|
| free cash flow per share | 17.99 |
| cash per share | 16.30 |
| operating cash flow per share | 19.74 |
| free cash flow operating cash flow ratio | 0.91 |
| cash flow coverage ratios | 0.59 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 11.31 |
Frequently Asked Questions
When was the last time Biogen Inc. (NASDAQ:BIIB) reported earnings?
Biogen Inc. (BIIB) published its most recent earnings results on 30-10-2024.
What is Biogen Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Biogen Inc. (NASDAQ:BIIB)'s trailing twelve months ROE is 10.06%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Biogen Inc. (BIIB) currently has a ROA of 5.82%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BIIB's net profit margin stand at?
BIIB reported a profit margin of 17.23% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BIIB's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.35 in the most recent quarter. The quick ratio stood at 0.90, with a Debt/Eq ratio of 0.28.